The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that the drug showed great promise for people with autism. The agency said it…[#item_full_content]
SpaceX Aims for $75 Billion IPO at $135 per Share
Giugno 3, 2026
SpaceX plans to raise $75 billion in its initial public offering by selling 555.6 million shares at a target price of $135 per share, a
